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The true incidence of apical prolapse is not clear because most of previous epide-
miologic studies were performed before 1996, in which the standardized system for
evaluating pelvic organ prolapse (pelvic organ prolapse-quantification, POP-Q) was
introduced. A recent study documented that in older women with an intact uterus,
14.2% had uterine prolapse.1 Even though the incidence of posthysterectomy vault
prolapse is also not clear, it has been reported to be 11.6% when hysterectomy was
performed for genital prolapse and 1.8% when performed for other benign diseases.2
Many surgical approaches have been introduced to correct apical prolapse,
however, abdominal sacrocolpopexy (ASC), proposed by Lane in 1962, has most
widely been studied and has been shown to be reliable and durable.3 Nonetheless,
most previous studies reported short- or intermediate-term follow-up data, inade-
quately evaluated pelvic organ prolapse and have not addressed in detail the
outcomes on pelvic floor dysfunction and major complications, for which reope-
ration or intensive care may be required. Moreover, many studies have reported
the post-surgical results through inappropriate surgical techniques (i.e., simple
attachment of mesh to vaginal apex instead of to the anterior and posterior vagina).
The aim of this study was to evaluate the long-term treatment outcome and
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years. Forty-seven women with urodynamic stress incontinence concomitantly received a modified Burch
colposuspension. The long-term anatomical and functional outcomes and complication rates were assessed. Results:
The median follow-up was 66 months (range 60-108). Overall anatomical success rates (no recurrence of any prolapse
≥ stage II according to the pelvic organ prolapse-quantification system) were 86.0%. Urinary urgency and voiding
dysfunction were significantly improved after surgery, however, recurrent stress urinary incontinence developed in
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incontinence) and sexual function (sexual activity and dyspareunia) did not significantly change after surgery. Major
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major complication rates of ASC. 
A total of 65 women underwent ASC for symptomatic
uterine or vault prolapse at the Department of Obstetrics
and Gynecology, Division of Female Pelvic Medicine and
Reconstructive Surgery, Yonsei University Health System,
Seoul, Korea between March 1999 and March 2003. Of
them, 57 women who attended follow-up visits for at least
5 years were included in this retrospective study [8 women
were excluded due to follow-up loss (n = 4) and short-term
follow-up visits (n = 4)]. The study was approved by our
Institutional Review Board.
All patients were preoperatively assessed through a
standard history taking, pelvic examination and urodynamic
study. Standard history taking consisted of age, parity,
body mass index, menopause and hormone replacement
therapy status, previous hysterectomy and pelvic recons-
tructive surgery, and urinary (urinary urgency, stress urinary
incontinence, voiding dysfunction), bowel (constipation,
fecal incontinence) and sexual (sexual activity, dyspareunia)
symptoms. Urinary urgency and stress urinary incontinence
were defined according to the recommendations of the
International Continence Society.4 Voiding dysfunction
was defined as weak urine stream or urinary retention.
Constipation was evaluated according to Rome II criteria.5
Fecal incontinence was defined as the involuntary loss of
solid or liquid stool per rectum. The woman who had sexual
intercourse more than once a month was considered “sex-
ually active.” Pelvic examinations were performed in a 45O
upright sitting position during a Valsalva’s maneuver with
maximal effort by the same examiner (S.W. Bai). Pelvic
organ prolapse was quantified according to the POP-Q
system.6 Urodynamic studies (Dantec-5000, Copenhagen,
Denmark) included uroflowmetry, multichannel cystometry,
measurements of Valsalva leak point pressure, and urethral
pressure profilometry. Measurements of Valsalva leak
point pressure were performed with bladder volumes of
200 mL with manual reduction of prolapse. 
All procedures were performed by one senior surgeon
(S.W. Bai). Teflon (polytetrafluoroethylene, CR Bard,
Covington, GA, USA) and Marlex mesh (polypropylene,
CR Bard, Covington, GA, USA) were employed during
this study period. The mesh was fashioned from two sheets,
both 10 cm in length and tapering from a width of 5 cm at
the vaginal end to 3 cm at the sacral end. The surgical
techniques were as follows: 
Surgical techniques
The patients were placed in a dorsal lithotomy position in
Allen-type stirrups. Laparotomy was performed through a
Pfannenstiel incision. For patients with urodynamic stress
incontinence, a modified Burch colposuspension was per-
formed with non-absorbable sutures (2-0 prolene, mono-
filament polypropylene) prior to entering the peritoneal
cavity as previously described.7 After entering peritoneal
cavity, hysterectomy was performed. If the uterus had
already been removed, after identifying the vaginal vault,
its overlying peritoneum was dissected away, exposing the
superior aspects of the pubocervical and rectovaginal
fascia to provide a sufficiently broad area of at least 3×5
cm for attaching the mesh. Then, the peritoneum over the
sacral promontory was incised vertically and loose areolar
tissues were gently dissected to expose the anterior longi-
tudinal ligament overlying the sacrum, taking care to avoid
the injury of presacral vessels. The peritoneal incision was
extended to the posterior cul-de-sac with caution to avoid
damage to the rectum or the ureter. Three non-absorbable
sutures (5-0 black braided silk sutures, Mersilk) were
placed just below the level of the sacral promontory and
the sutures were tagged with curved hemostat clamps.
Then, elevating the vaginal vault cephalad using sponge
sticks placed into the vagina, three delayed absorbable
sutures (2-0 polysorb, coated braided lactomer) were placed
on the anterior and posterior vaginal wall, one delayed
absorbable suture (2-0 polysorb, coated braided lactomer)
on each side of the vaginal vault, respectively. The sutures
were brought through the two pieces of mesh, tied down,
and cut. The appropriate length of the mesh was determined
as one that avoids any tension on the mesh and vagina. The
excess mesh was cut and removed, and the promontory
sutures were then brought through the remaining mesh and
tied down. After betadine irrigation, retroperitonealization
of the mesh was performed with interrupted 2-0 cat-gut
chromic sutures. Then, the abdomen was closed in the
usual manner. Posterior colporrhaphy was done in all but
one woman to treat remnant posterior defects.
Patients were followed up at 1, 3, 6, and 12 months after
surgery, and annually thereafter. At each visit, urinary,
bowel, and sexual symptoms, and other problems were
assessed by the same physician (S.W. Bai). The changes of
POP-Q stage were also examined. 
The Mann-Whitney U test, Fisher’s exact test and chi-
square test were used for statistical analysis using the
SPSS software 14.0 (SPSS Inc, Chicago, IL, USA). A p-
value < 0.05 was considered statistically significant. 
Table 1 shows preoperative clinical and demographic
characteristics of the study population. The median follow-
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up was 66 months (range 60-108). 
Anatomical treatment outcomes
Anatomical success rates were 100% when defined as lack
of apical prolapse ≥ stage II postoperatively, and 86.0%
when defined as no recurrence of any prolapse ≥ stage II
(Table 2). All recurrences were observed in cases having
undergone concomitant modified Burch colposuspension.
However, when compared to cases not having undergone
concomitant Burch colposuspension, there was no signi-
ficant difference in recurrence rates of anterior prolapse
(3/47 vs. 0/10, p = 1.000) and posterior prolapse (7/47 vs.
0/10, p = 0.333). The median recurrence time was 18
months (range 3-60 months). Five women experienced the
recurrence within 2 years [2 (3 months), 1 (6 months), 1
(12 months), and 1 (24 months)], however, 3 had relapse
of prolapse after 2 years [1 (48 months), 1 (36 months), and
1 (60 months)]. Two women with symptomatic recurrent
prolapse were treated using pessary. 
Functional outcomes 
Following surgery, overall urinary function was significantly
improved, however, 44.7% (21/47) of women experienced
recurrent stress urinary incontinence, which was defined as
the presence of stress-incontinence symptom and positive
cough stress test after surgery (Table 3). The median
recurrence time was 3 months (range 1-84 months). Of
them, 2 underwent reoperation [1 (sling operation, cured),
and 1 (tension-free vaginal tape, not cured)]. The incidences
of de novo urinary urgency, de novo stress urinary incon-
tinence, and de novo voiding dysfunction were 5/35 (14.3%),
1/10 (10.0%), and 1/46 (2.2%) respectively. Of 13 women
who had constipation preoperatively, 3 (23.1%) had
persistent symptoms after surgery. Three (6.8%) women
complained of newly developed constipation following
surgery. One woman who had fecal incontinence preoper-
atively, still had symptoms after surgery and another
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Table 1. Preoperative Characteristics of the Study Population
Study group (n = 57)
Age (yrs, mean ± SD) 62.2 ± 10.0
Parity (median, range) 3 (1 - 10)
Body mass index (kg/m2, mean ± SD) 24.1 ± 2.9
Menopause (n, %) 52 (91.2)
Hormone replacement therapy (n, %) 8 (15.4)
Prior hysterectomy (n, %) 19 (33.3)
Prior pelvic reconstruction (n, %) 6 (10.5)
POP-Q stage (n, %)
III 24 (42.1)
IV 33 (57.9)
POP-Q, pelvic organ prolapse-quantification.
Table 2. Pre- and Postoperative (at Last Follow-Up Visit) POP-Q Stages 
Compartment Stage Preoperative (n, %) Postoperative (n, %)
Apical 0 0 52 (91.2)
I 0 5 (8.8)
II 11 (19.3) 0
III 17 (29.8) 0
IV 29 (50.9) 0
Anterior 0 1 (1.8) 48 (84.2)
I 1 (1.8) 6 (10.5)
II 2 (3.5) 2 (3.5)
III 23 (40.4) 1 (1.8)
IV 30 (52.6) 0
Posterior 0 0 42 (80.7)
I 0 8 (12.3)
II 13 (22.8) 5 (7.0)
III 19 (33.3) 2 (3.5)
IV 25 (43.9) 0
Overall 0 0 36 (63.2)
I 0 13 (22.8)
II 0 6 (10.5)
III 24 (42.1) 2 (3.5)
IV 33 (57.9) 0
POP-Q, pelvic organ prolapse-quantification.
woman complained of de novo fecal incontinence. Thirty-
seven women who had been sexually inactive preoperati-
vely did not resume sexual activity after surgery. Of 20
sexually active subjects before surgery, 1 (5.0%) did not
have sexual intercourse after surgery because of dyspa-
reunia due to mesh erosion.
Complications
The incidences of peri- and postoperative complications
are presented in Table 4. Major complication requiring
reoperation or intensive care developed in 12 (21.0%) cases.
Two women were hospitalized for a long period due to
wound infection or small bowel obstruction. And 8 women
underwent reoperation for the complication. One experien-
ced deep vein thrombosis at the postoperative third day
and required thrombectomy because of no response to
medical treatment. Three experienced incisional hernia and
underwent reoperation (at 4 months, 4 years, and 6 years
after surgery). Right ureteral obstruction occurred 3 years
post op in 2 cases and they underwent reoperation (1 un-
derwent stent insertion and 1 received right nephrectomy).
Vaginal vault healing problems were noted only in cases
using Teflon mesh [4/26 vs. 0/31 (Teflon mesh), p = 0.038].
Of the 38 women who underwent a hysterectomy at the
time of ASC, 4 (20.0%) had erosion, but, no mesh erosion
occurred (p = 0.290) in 19 women who did not receive a
hysterectomy concomitantly. All events happened between
1 to 3 years after surgery. Two cases were cured by the long-
term treatment with local estrogen and antibiotics, and in
the rest 2 cases, conservative treatment failed because of
infection and reoperation was performed for mesh removal. 
In spite of extensive studies on the treatment outcomes of
ASC, there have been few reports on its long-term efficacy
and safety. Moreover, in previous studies those presenting
a long-term outcome, adequate information cannot be
acquired because of inadequate evaluation of pelvic organ
prolapse, poor description of the pelvic floor dysfunction,
and the use of inappropriate surgical techniques (Table 5).7-11
In the present study, we confirmed the long-term efficacy
of ASC. The anatomical success rates were 100% for apical
prolapse and 86.0% for any prolapse. Failures after ASC
typically occur in other compartments, which have been
reported as having values up to 29% and 57% in the
anterior and posterior compartments, respectively.12,13
Besides the difference in pelvic organ prolapse evaluation
system employed and definition of recurrence, relatively
low recurrence rates in the present study can be explained
by the difference in surgical techniques. There have been
several modifications in the surgical techniques used since
the introduction of particular surgical techniques by Lane.
One major difference is the attachment of the mesh to the
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Table 3. Pre- and Postoperative (at Last Follow-Up Visit) Pelvic Floor Dysfunction  
Preoperative Postoperative 
Urinary urgency (n, %) 22 (38.6) 8 (14.0)*
Stress urinary incontinence (n, %) 47 (82.5) 22 (36.8)*
Voiding dysfunction (n, %) 11 (19.3) 2 (3.5)*
Constipation (n, %) 13 (22.8) 6 (10.5)
Fecal incontinence (n, %) 1 (1.8) 2 (3.5)
Sexual inactivity (n, %) 37 (64.9) 38 (66.7)
Dyspareunia (n, %) 2 / 20 (10.0) 2 / 20 (3.5)
Aware of prolapse (n, %) 57 (100) 2 (3.5)*
*p value < 0.05 (compared with preoperative status).
Table 4. Periop- and Postoperative Complications  
Complication n (%)
Intraoperative blood loss requiring 
3 (5.3)
transfusion
Intraoperative bladder, ureter and 
0
bowel injury
Deep vein thrombosis 1 (1.8)
Wound infection 1 (1.8)
Incisional hernia 3 (5.3)
Ureteral obstruction 
Teflon mesh (n = 26) 0  
Marlex mesh (n = 31) 2 (6.5)
Small bowel obstruction 
Teflon mesh (n = 26) 0
Marlex mesh (n = 31) 1 (1.8)
Vault healing problem
Teflon mesh (n = 26) 4 (15.4)
Marlex mesh (n = 31) 0
Reoperation for the complication 8 (14.0)*
*Reason for reoperation; 1 (deep vein thrombosis), 2 (mesh infection), 2 (right 
ureteral obstruction), 3 (incisional hernia).
DISCUSSION
anterior and posterior vaginal walls, not
simply to the vaginal apex. This modifi-
cation can lead to good support of the
anterior and posterior compartments as
well as of the apical compartment, rein-
forcing and treating the vaginal fascial
defects at DeLancey’s levels 1 and 2.7
Modified Burch colposuspension con-
comitantly performed with ASC can also
affect the recurrence rates of anterior and
posterior prolapse, however, we were not
able to find any significant influence in
this study. In the study investigating the
recurrence rates using POP-Q system,
Culligan, et al.14 noted that nearly all recur-
rences occurred within 2 years postop
and concluded that it is reasonable to
construct randomized controlled trials
involving ASC that only a 1- or 2 year
follow-up. However, only 30% of women
were followed up at least 4 years after
surgery, and 22.4% of them were eval-
uated according to POP-Q in his study.
In our study, the median recurrence time
was 18 months. Nearly half of the recur-
rence occurred after 2 years. These find-
ings indicate that short- or intermediate-
term follow-up is not enough in studies
involving ASC.
Also, the long-term outcomes of pelvic
floor dysfunction (except in the case of
stress urinary incontinence) after ASC
have been poorly described in previous
studies. Most studies have shown that
Burch colposuspension combined with
sacrocolpopexy is less effective than Burch
colposuspension alone.8-12,15,16 Similarly,
nearly half of the women in our study
experienced recurrent stress urinary incon-
tinence and half of them developed within
a postoperative period of 1-3 months,
corresponding with the resumption of
normal activity. These cases might have
been due to the effect of ASC, since there
was no case with low maximal urethral
pressure (≤ 20 cmH2O) on preoperative
urodynamic study. ASC may flatten the
anterior vaginal wall and urethrovesical
angle, and the opposite forces resulting
from ASC and Burch colposuspension
might have been responsible for subopti-
mal Burch colposusension results.8 Fur-
Long-Term Treatment Outcome of Sacrocolpopexy
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ther studies will be needed to evaluate whether another
procedure such as a sling improves continence status further.
In the present study, urinary urgency and voiding dys-
function were significantly improved, possibly as a result
of prolapse correction, however, bowel functions were not
improved after surgery. This finding is consistent with the
results of other studies.3 Lack of bowel function improve-
ment may be explained by the fact that bowel function can
be influenced by several pathologic conditions besides
rectocele. In one study, women with preoperative patholo-
gic transit conditions and paradoxic sphincter reaction had
constipation after rectocele repair.17 Sexual activity also did
not change after surgery. The impact of prolapse itself on
sexual activity may be little. The main causes of preo-
perative sexual inactivity in this study population were an
absent partner (40.5%) and no desire for sexual intercourse
(48.7%). The rest of causes was partner’s illness (5.4%)
and patient’s underlying illness (5.4%). All patients with
preoperative sexual inactivity did not resume sexual activity
postop. 
Complications of ASC have also been poorly described
in previous studies except for intraoperative complications
(i.e., massive bleeding, visceral organ injury) and mesh
erosion. We found significantly high rates of major com-
plication requiring readmission for intensive care or
reoperation, which may be partly due to the use of inappro-
priate mesh; that is, Teflon mesh. Teflon mesh is type III
mesh, which has microporous component, and prone to
infection and subsequent wound healing problem.18 A
recent study showed a significant high risk of mesh erosion
in women who had polytetrafluoroethylene (Teflon, or
Goretex) mesh compared to those with non-polytetrafluo-
roethylene mesh.19 Concomitant hysterectomy might also
have contributed to high mesh erosion rate.19 Even though
no significant difference was found in this study because
of relatively small number of the study population, mesh
erosion occurred only in women who had undergone con-
comitant hysterectomy. 
The major weakness of this study was retrospective in
nature and the small sample size. However, the percentage
of follow-up loss was low (12.0%) compared with other
studies. In addition, we used the standardized POP-Q
system for the evaluation of prolapse and thoroughly inves-
tigated pelvic floor dysfunction and its complications. The
second drawback was the lack of use of validated question-
naires on pelvic floor dysfunction, which were not available
for us in this study period. Instead using validated question-
naires, we tried to assess pelvic floor dysfunction symptoms
according to specific definitions or criteria. 
ASC provides durable pelvic support, however, it may
be ineffective for alleviating pelvic floor dysfunction except
for urinary urgency and voiding dysfunction, and it con-
tains major complication risk that cannot be overlooked.
Large population-based long-term follow-up studies
using disease-specific validated questionnaires on pelvic
floor dysfunction are needed in the future to draw a more
definite conclusion.
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